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SUMMARY
We analysed the reactivity of enterovirus-specific human IgM and IgG antibodies
with the structural proteins of different enteroviruses by the immunoblot technique.
In general, all immunoglobulin G antibodies of the tested sera reacted with capsid
polypcptidc VP 1 of the viruses tested (echoviruses 9 and 11, coxsackievirus B3
and poliovirus 2). In contrast, cnterovirus specific immunoglobulin M antibodies
of adults reacted with capsid polypcptidcs VP 1, VP 2, and/or VP 3 of the viruses
mentioned above. The reactions with VP 2 and/or VP 3 were often stronger than
with VP 1. IgM antibodies from sera of newborns infected by echo virus 11 reacted
with VP 1 and VP 2/3 of cchovirus 11 and also with VP 2 and VP 3 of poliovirus
2. Prcabsorption experiments indicate that cross-reactive IgG antibodies react
with epitopes of VP 1 not present on the surface of intact virus particles. The
results from the immunoblot technique were compared to data from microncu-
tralization tests and M-antibody capture radioimmunoassays.
INTRODUCTION
Recently developed IgM specific assays (MACRIA) (Burkhardt, Reigcl & Schilt,
1983; El-Hagrassy, Banatvala & Coltart, 1980; Morgan-Capncr & McSorloy, 1983;
Pattison, 1983) for the diagnosis of cnterovirus infections and other scrological test
8ystcms such as complement-fixation (Bussel el al. 1902; Haloncn, Rosen &
Hucbner, 1959; Kraft & Melnick, 1952; Schmidt, Dennis & Lcnncttc, 1902),
haemagglutination-inhibition (Bussel el al. 1902), irnmunodiffusion (Schmidt,
MagofTin & Lcnnettc, 1973), counterimmunoclcctrophoresis (Minor et al. 1979) or
nolid-phasc immunoassays (Katze & Crowcll, 1980a, b\ King et al. 1983) showed
cross-reactivities of IgM antibodies to hcterologous viruses. Apparently type-
specific reactions in a 'reverse IgM RIA' were described by Torfason, Frisk &
Diderholm (1984) using purified virions as antigen.
We were therefore interested to know which virus structural proteins are
associated with the cross-reactivity. We recently showed that IgM antibodies from
«era of echovirus 11 infected persons reacted to VP 1, VP 2 and VP 3 of cchovirus
H, whereas IgG antibodies reacted exclusively to VP 1 (Rcigel, Burkhardt &
Schilt, 1984).
Other data lead to the conclusion that cross-reactivity of IgM antibodies
10-2
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depends on the age of the patients (King el al. 1983). We therefore analysed the
reactivity of IgM and IgG antibodies from sera of enterovirus-infected newborns
to determine whether they cross-reacted with proteins of heterologous enteroviruses
or whether a primary enteroviral infection of humans induces type-specific IgM
antibodies.
In this study we describe the reactions of IgM and IgG antibodies of sera from
echovirus 11 infected newborns and sera from adult persons with various enterovirus
infections. Sera were tested for reactions with the structural proteins of echovirus
11, coxsackievirus B3, poliovirus 2 and some of those of echovirus 9.
MATERIALS AND METHODS
Sera. Sera from adults were collected from enterovirus outbreaks (ochoviruses
9 and 11) or from sporadic infections caused by different enteroviruses, and sera
of newborns from an echovirus 11 outbreak in an infant ward. In all cases cither
the infecting virus was isolated, and/or a fourfold increase of neutralizing
antibodies in paired sera was shown, and/or the presence of IgM antibodies was
demonstrated using M-antibody capture radioimmunoassays (MACRIA) to
echoviruses (Burkhardt, Reigel & Schilt, 1983) and hepatitis A (HAV, enterovirus
72; Flehmig, 1978). Briefly, polystyrene beads coated with anti-human IgM
antibodies were incubated with diluted sera. After washing the antigen was added
and the bound antigen was detected by incubation with mI-labcllcd anti-echovirus
9, anti-echovirus 11 or anti-HAV specific antibodies. Sera were fractionated by
centrifugation through 10-40% sucrose gradients in phosphate-buffered saline
(PBS) and the IgG- and IgM-containing fractions were pooled and used for
immunoblot testing. Some sera from newborns and control sera taken from
umbilical cord blood were used without fractionation.
[3i8]methionine'labelled viral proteins. Vero cell monolaycrs were infected with
the different enterovirus strains at a multiplicity of infection of ^ 1 plaque forming
unit (p.f.u.) per cell until the cytopathic effect was first visible. Then the medium
was replaced by mcthionino-frco minimal essential medium (MEM) without serum
and the viral proteins were labelled with 5 /zCi/ml [36S]mcthioninc (New England
Nuclear, Boston, USA) until cytopathic effects were complete. Labelled viruses
were isolated as described below.
Viruses. Prototype strains Hill (cchovirus 9), Gregory (echovirus 11), Nancy
(coxsackievirus B3) and Lansing (poliovirus 2) were propagated in Vcro cells and
the viruses isolated by CsCl density-gradient centrifugation as described for
echovirus 11 (Reigel, Burkhardt & Schilt, 1984). Virions banding at a density of
1*34 g/cm3 were used as antigens. This virus material was sedimented by ultra-
centrifugation (130000 g, SVV 27-0) and the virus particles disrupted by boiling for
2min at 100 °C in sample buffer (G2-5 HIM Tris/HCl, pH 0-8, 2% SDS 5%
mercaptoethanol, 10% glycerin and bromophenolblue) and then separated by
polyacrylamide gel elcctrophoresis.
Immunoblottincj. The method has been described in detail (Reigel, Burkhardt &
Schilt, 1984). Briefly, viral proteins were isolated from purified virions by
polyacrylamide gel electrophoresis according to Laemmli (1970), as modified by
Weintraub, Palter & van Lcnte (1975). The proteins were then transferred from
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Table 1. Serological data: sera of adults
Patiiien
1§
2§
3
4
5
G
7
Infecting
t virus
Echovirus 11
Echovirus 9
HAV
Coxsackievirus B3
Coxsackievirus B5
Coxsackievirus A9
Poliovirus 2
Neutralizing antibody titre*
Echo
9
<10
G40
<10
<10
<10
<10
<10
Echo
11
320
<10
80
<10
80
<10
< 10
CB
3
<10
<10
20
40
40
160
<10
CB
5
—
—
—
—
320
—
CA
9
—
—
—
—
80
__
to
Polio
2
40
20
10
10
80
80
^G40
IgM antibodies
Virus-specificf
Echo
9
13-7
i4-9
0 0
159
0 0
8-9
1-4
*
Echo
11
230
3-5
0-7
8*4
0 5
103
0-0
HAV
0-9
0-9
20-7
0-8
0-9
0-9
0-9
TntnlX ULill
(i.u./
ml)*
150
190
500
170
150
225
140
* Determined in microneutralization tests against 50TCID50 of virus per assay.
t Figures are test-negative ratios (^2*1 is negative).
% Determined using NOIt-IgM plates (Bering, Marburg, Germany): 100 i.u. is equivalent to
089 g/1.
§ Patients 1 and 2 are representatives from persons infected during two enterovirus outbreaks
(Kurkhardt, Heigel & Schilt, 1983).
the gel to nitrocellulose (western blotting; Towbin, Staehelin & Gordon, 1979).
Nitrocellulose strips containing the viral proteins were incubated with human sera
find the immune reactions visualized by incubation with peroxidasc-conjugatcd
anti-human IgM or IgG specific antibodies followed by the dye reaction. The dye
Used was o-dianisidinc. Peroxidase-conjugated anti-human IgG or anti-human IgM
specific immunoglobulins were obtained from DAKO (DAKO Immunoglobulins,
Denmark) and tested for specificity by F. Skvaril, Berne. Peroxidasc-conjugatcd
anti-IgG immunoglobulins were used at a 1 in 200 dilution and anti-IgM
immunoglobulins at a 1 in 100 dilution. IgG- and IgM-containing fractions of
human sera or unfractionated sera from newborns were diluted with 3 % FCS-PBS
find used for the immunoblot reactions at final dilutions of 1 in 25 for IgM and
1 in 100 for IgG antibodies.
RESULTS
Serological data of sera. The tables summarize the results of neutralizing antibody
MACRIA activity for seven sera from the acute phaso of different enterovirus
infections from adult persons (Table 1) and from six newborns infected by
cchovirus 11 (Table 2). In one case, serum from the mother was available and the
data are included in Table 2.
Sensitivity and specificity of the immunoblot reactions. To obtain optimal conditions
We used a checker-board titration system on the immunoblots for echovirus 11.
We analysed dilutions of serum I (Table 1) from 1 in 25 to 1 in 5000 and virus
particles of 10° to 10° p.f.u. per slot. Optimal conditions for best visible bands were
found at a dilution of IgM antibodies of ^ 1 in 100 and of proteins from ^ 108 p.f.u.
per strip. Using 10° p.f.u. per slot, reactions could be demonstrated up to scrum
dilutions of ^1 in 1000, while 107 or less p.f.u. per slot did not lead to visible
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Table 2. Serological data: sera ofnewborns
Patient
X1180
XU81
X1182
X1201
XI072
XI083
XI774
Age
2 weeks
2 weeks
2 weeks
1 week
1 week
Day
after
onset
of
illness
0
12
49
0
40
0
12
31
2
01
0
Mother of XI072
3 weeks 12
Neutralizing antibody titre
Echo G Echo 9
<10 20
<10 40
<10 20
<10 10
<10 20
<10 10
10 10
<10 <10
n.d. <10
<10 10
Echo 11
100
80
80
320
320
320
10
10
80
CB3
n.d.
1C0
n.d.
n.d.
100
n.d.
80
n.d.
n.d.
<10
<10
20
n.d.
to
Polio 2
n.d.
40
n.d.
n.d.
20
n.d.
20
n.d.
n.d.
20
10
20
n.d.
IgM
Virus specific
Echo 9
0-4
0-4
0-3
0-3
0-5
0-5
00
0-4
10
03
0 0
n.d.
1-1
Echo 11
0-6
10-2
2-9
15-5
8-1
0-3
16-0
«• 30
0-5
31
0-2
0 0
140
Total
(i.u./m
100
180
140
205
125
GO
155
110
50
155
140
n.d.
205
Footnotes as for Table 1. X1180 and XI182 are twins, n.d., Not determined.
reactions. IgG antibodies were in some cases tested at a 1 in 10 dilution and showed
no additional reactions. Sera were routinely fractionated for testing of JgM specific
reactions. Unfractionated sera gave similar results.
Serum from umbilical cord blood did not show JgM specific reactions to
structural proteins of cchoviruses 9 and 11, coxsackievirus B3 and poliovirus 2.
Sera of adults presented here did not react to proteins from uninfected Vcro cells
(control antigen) at the supposed positions of the viral structural proteins.
Reactions of IgG antibodies to the viral stniclural proteins. Figs. 1-5 show the
reactivity of the sera from different enterovirus infections to viral structural
proteins of echoviruses 9 and 11, coxsackievirus B3 and poliovirus 2.
IgG antibodies from adult sera 1-7 and from sera of six newborns all reacted
to VP 1 of all viruses tested (Figs. 1A-5A) irrespective of the presence or absence
of neutralizing antibodies to the corresponding viruses (Tables 1 and 2). In adult
sera a weak reaction to VP 2 of poliovirus 2 may be detected (Fig. 4 A, lanes 1-4,
C, 7). Also sera from umbilical cord blood showed IgG reactions to capsid
polypeptide VP 1 of echovirus 11, echovirus 9, coxsaekiovirus B3 and poliovirus
2 (data not shown).
An additional 24 sera from infections of adults caused by cchoviruses 9, 11, 30,
coxsackicviruscs B2 to BG, polioviruscs 1 and 2, coxsackievirus A9 and IIAV were
tested for the reactivity to the structural proteins of echovirus 11 and six additional
sera for reactions to viral proteins of cchovirus 9. All sera showed IgG specific
reactions to VP 1 of echoviruses 9 and 11 respectively (data not shown).
Preabsorption of sera from echovirus 11 infected adults with intact echovirus
11 led to the disappearance of JgG reactions with VP 1 of echovirus 11 and poliovirus
2. This reaction was again observed after disruption of the antigen-antibody
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complexes at pH 2-2. Preabsorption with intact polio virus 2 did not change the
reaction pattern (data not shown).
Reactions of IgM antibodies with the viral structural proteins. In contrast to the
IgG reactions described above we found additional reactions with VP 2 and/or
VP 3 of the viruses tested for IgM antibodies of the sera from adults. IgM
antibodies from sera of echovirus 11 infected newborns showed reactions with
VP 1, VP 2/3 of echovirus 11 and with VP 2 and VP 3 of poliovirus 2. Weak
reactions with VP 1 of coxsackievirus B3 may be detected in some cases on the
original strips (not shown).
The results of the IgM-specific reactions are shown in Figs. 1 B-5B. We classified
the reactions as strong and weak according to a visual reading of the colour chart.
Reactions with proteins other than viral structural proteins, which are seen on
some blots, have not been analysed. "•
Six additional sera from different enterovirus infections of adult persons,
including sera from an echovirus 9 outbreak, were tested for IgM reactivity with
the structural proteins of echovirus 9. All sera showed strong reactions with VP 3
and a weak reaction with VP 1 (data not shown).
Sera from echoviruses 9 and 30, coxsackievirus A9, coxsackieviruses J34 and BO,
HAV, and poliovirus 1 infections were also tested for IgM reactions with viral
proteins of poliovirus 2. In general, good reactions were found with VP 2 and VP 3
and weaker reactions with VP 1 (data not shown).
Other sera tested showed best reactions to VP 2 and weaker reactions witli VP 1
and/or VP 3 of coxsackievirus B3 (data not shown).
After preabsorption of sera from echovirus 11 infections with intact echovirus
11, IgM reactions with VP 2/3 of echovirus 11 disappeared. Preabsorption with
poliovirus 2 did not change the reaction pattern. Incubation of serum at pll 2*2
before testing strongly reduced the reactivity with VP 2/VP 3, while centrifugation
of serum at 16000 rev./min for 20 min did not change the reactions (data not
shown).
DISCUSSION
The present results using the immunoblot technique show that JgG antibodies
from sera of adult patients infected by echoviruses 9, 11 and 30, polioviruses 1 and
2, coxsackieviruses B2 to BO, coxsackievirus A9 and hepatitis A as well as sera
from newborns infected by eehovirus 11 react mainly with the VP 1 protein of the
enteroviruses tested.
In contrast, IgM antibodies from .sera of adult por.sonH react with VP 2 and/or
VP 3 and with VP 1 of these viruses; IgM antibodies from sera of echovirus
11 infected newborns react with structural proteins of echovirus 11 and cross-react
with poliovirus 2. The IgM content in sera of newborns infected with eehovirus
11 (Table 2) was substantially increased compared to the amounts in normal
newborn sera and reached the values found in sera of adults. In all sera tested,
IgG-specifie reactions with VP 1 of the viruses mentioned were found. This
reactivity is explained by persisting IgG antibodies from earlier enterovirus
infections or poliomyelitis vaccination. Reactions with VP 1 proteins found for IgG
antibodies in sera, where \\ e did not detect neutralizing activity to the corresponding
virus, must be explained by cross-reactivity of the antibodies with epitopes of the
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VP 1 proteins of the different enteroviruses. As may be expected, umbilical cord
blood from healthy newborns also showed these reactions as a consequence of
trans-placental transport of maternal enterovirus-specific IgG antibodies to the
fetus. Early studies (Kraft & Melnick, 1952; Bussell et al. 1962; Schmidt et al.
1962a; Schmidt, Dennis & Lennette, 19626; Schmidt, Magoffin & Lennette, 1973;
and other investigators) showed type-specific as well as group-reactive determinants
among enteroviruses. Recent studies show that important epitopes leading to
neutralizing antibodies are located on VP 1, provided that the virus particles are
intact. Heated or denatured virus particles show different degrees of cross-
reactivities (Bittle et al. 1982; Emini, Ostapchuk & Wimmer, 1983; Emini,
Jameson & Wimmer, 1983; Evans et al. 1983; Haresnape & MaCahon, 1983;
Hasegawa & Inouye, 1983; Robertson et al. 1983; Wychowski et al. 1983; Thorpe
et al. 1983). Our results indicate that group-reactive determinants detected by IgG
antibodies are located on the VP 1 proteins of the tested viruses. Preabsorption
of the sera with intact virus indicates that these epitopes are not located on the
surface of the virus particles.
In addition to the broad cross-reactivity with VP 1 proteins shown for IgG
antibodies in this study, we observed that igM antibodies reacted on the
immunoblot with VP 1, and/or VP 2 and/or VP 3. This is in contrast to published
results (Dorries & ter Meulen, 1983; Mertens, Pika & Eggers, 1983). Moreover, IgM
antibodies from different enterovirus infections cross-reacted to structural proteins
of other enteroviruses. This may be in accordance with recent findings that
enteroviruses contain a highly conserved region in the nudeotide sequence between
bases 220 and 1809, where the entire polypeptide VP 2 and part of VP 3 are
encoded (Rotbart, Levin & Villareal, 1984). Preabsorption experiments with intact
virus and the lability of these reactions in sera pretreated by incubation at pli 2*2
indicate that IgM reactions to VP 2/VP 3 may be elicited by immune complexes
in the sera. This, however, must be substantiated by more extensive experimental
data. Cross-reactivity of IgM antibodies among enteroviruses has been described
previously in other serological tests, namely complement-fixation, haemaggluti-
nation-inhibition, immunodifTusion, MACRIA, counterimmunoelectrophoresis or
indirect solid-phase immunoassays. Type-specific IgM reactions were found by
Schmidt, Magoffin & Lennette (1973) in their gel-diffusion technique in 80% of all
positive cases. Schilt (1977) showed for a few sera that IgM antibody-containing
serum fractions gave type-specific results in neutralization tests and Torfason,
Prisk & Diderholm (1984) reported type-specific reactions in a reverse IgM III A.
The degree of cross-reactivity may be explained by the particular presentation of
the antigens in the different systems and, therefore, the results may not be directly
comparable.
Studies of King ft al. (1983) showed that sera from young children behaved most
type-specifically in ELISA and that heterotypie responses increased with age. Our
earlier (Burkhardt, Reigel & Schilt, 1983) and the present studies using sera from
adult persons infected by different enteroviruses, from newborns (1-2 weeks old)
infected by echovirus 11 and our control sera from umbilical cord blood support
these findings.
The immunoblot technique used to detect enterovirus-specific IgM and IgG
antibodies could be extended to give quantitative measurements of IgG and IgM
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antibodies during infections and convalescence. It would also be interesting to see
whether small peptides derived from the viral structural proteins, which were
shown to induce neutralizing antibodies, also behave type-specifically on the
immunoblot.
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